Jervoise Andreyev, MA, PhD, FRCP of The Royal Marsden NHS Foundation Trust, London, United Kingdom discusses the need for a multidisciplinary team approach to cancer care. Specialists from various fields like neuropathy, pain management, or dietetics need to work together to give patients the best possible care. Dr Andreyev highlights the importance of building links with other experts, who could help with treatment decisions when necessary. Data show that between 5-40% of the multidisciplinary team (MTD) decisions are changed by having the right person in the group. Dr Andreyev recommends a similar approach to MTD decision making for side effects management, which could benefit patients’ Quality of Life (QoL). Patients would be less likely to get dose reductions, which could lead to better outcomes. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia.
